aluates Reports

$ 0.0

Automative

Global Lung Cancer Genomic Testing Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-36U14226

Global Lung Cancer Genomic Testing Market Research Report 2023

BUY CHAPTERS

Global Lung Cancer Genomic Testing Market Research Report 2025

Code: QYRE-Auto-36U14226

Report

April 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CD Genomics

Qiagen NV

Laboratory Corporation of America Holdings

Neogenomics Laboratories

Agilent Technologies Inc

Illumina Inc

Thermo-Fischer Scientific, Inc.

Abbott Laboratories Inc

Quest Diagnostics Inc.

OncoDNA

CENTOGENE N.V

Admera Health

CeGaT GmbH

OPKO Health Inc

F. Hoffmann-La Roche AG

Lung Cancer Genomic Testing Market

The global market for Lung Cancer Genomic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Lung Cancer Genomic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lung Cancer Genomic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Lung Cancer Genomic Testing in Hospitals/Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Lung Cancer Genomic Testing include CD Genomics, Qiagen NV, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Agilent Technologies Inc., Illumina Inc., Thermo Fischer Scientific Inc., Abbott Laboratories Inc., Quest Diagnostics Inc., OncoDNA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Genomic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Genomic Testing.

The Lung Cancer Genomic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer Genomic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Genomic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Genomic Testing Market Report

Report Metric	Details
Report Name	Lung Cancer Genomic Testing Market
Segment by Type	Liquid Biopsy Tissue Biopsy
Segment by Application	Hospitals/Clinics Research Organization Diagnostic Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CD Genomics, Qiagen NV, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Agilent Technologies Inc., Illumina Inc., Thermo Fischer Scientific Inc., Abbott Laboratories Inc., Quest Diagnostics Inc., OncoDNA, Centogene N.V., Admera Health, CeGaT GmbH, OPKO Health Inc., F. Hoffmann-La Roche AG.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Genomic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lung Cancer Genomic Testing Market report?

Ans: The main players in the Lung Cancer Genomic Testing Market are CD Genomics, Qiagen NV, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Agilent Technologies Inc., Illumina Inc., Thermo Fischer Scientific Inc., Abbott Laboratories Inc., Quest Diagnostics Inc., OncoDNA, Centogene N.V., Admera Health, CeGaT GmbH, OPKO Health Inc., F. Hoffmann-La Roche AG.

What are the Application segmentation covered in the Lung Cancer Genomic Testing Market report?

Ans: The Applications covered in the Lung Cancer Genomic Testing Market report are Hospitals/Clinics, Research Organization, Diagnostic Laboratories

What are the Type segmentation covered in the Lung Cancer Genomic Testing Market report?

Ans: The Types covered in the Lung Cancer Genomic Testing Market report are Liquid Biopsy, Tissue Biopsy

Recommended Reports

Genomic Cancer Testing

Lung Cancer Diagnostics

Cancer Molecular Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Genomic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Liquid Biopsy

1.2.3 Tissue Biopsy

1.3 Market by Application

1.3.1 Global Lung Cancer Genomic Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals/Clinics

1.3.3 Research Organization

1.3.4 Diagnostic Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Genomic Testing Market Perspective (2020-2031)

2.2 Global Lung Cancer Genomic Testing Growth Trends by Region

2.2.1 Global Lung Cancer Genomic Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lung Cancer Genomic Testing Historic Market Size by Region (2020-2025)

2.2.3 Lung Cancer Genomic Testing Forecasted Market Size by Region (2026-2031)

2.3 Lung Cancer Genomic Testing Market Dynamics

2.3.1 Lung Cancer Genomic Testing Industry Trends

2.3.2 Lung Cancer Genomic Testing Market Drivers

2.3.3 Lung Cancer Genomic Testing Market Challenges

2.3.4 Lung Cancer Genomic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Genomic Testing Players by Revenue

3.1.1 Global Top Lung Cancer Genomic Testing Players by Revenue (2020-2025)

3.1.2 Global Lung Cancer Genomic Testing Revenue Market Share by Players (2020-2025)

3.2 Global Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lung Cancer Genomic Testing Revenue

3.4 Global Lung Cancer Genomic Testing Market Concentration Ratio

3.4.1 Global Lung Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Genomic Testing Revenue in 2024

3.5 Global Key Players of Lung Cancer Genomic Testing Head office and Area Served

3.6 Global Key Players of Lung Cancer Genomic Testing, Product and Application

3.7 Global Key Players of Lung Cancer Genomic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Genomic Testing Breakdown Data by Type

4.1 Global Lung Cancer Genomic Testing Historic Market Size by Type (2020-2025)

4.2 Global Lung Cancer Genomic Testing Forecasted Market Size by Type (2026-2031)

5 Lung Cancer Genomic Testing Breakdown Data by Application

5.1 Global Lung Cancer Genomic Testing Historic Market Size by Application (2020-2025)

5.2 Global Lung Cancer Genomic Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lung Cancer Genomic Testing Market Size (2020-2031)

6.2 North America Lung Cancer Genomic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lung Cancer Genomic Testing Market Size by Country (2020-2025)

6.4 North America Lung Cancer Genomic Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Genomic Testing Market Size (2020-2031)

7.2 Europe Lung Cancer Genomic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lung Cancer Genomic Testing Market Size by Country (2020-2025)

7.4 Europe Lung Cancer Genomic Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Genomic Testing Market Size (2020-2031)

8.2 Asia-Pacific Lung Cancer Genomic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lung Cancer Genomic Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Lung Cancer Genomic Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Genomic Testing Market Size (2020-2031)

9.2 Latin America Lung Cancer Genomic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lung Cancer Genomic Testing Market Size by Country (2020-2025)

9.4 Latin America Lung Cancer Genomic Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Genomic Testing Market Size (2020-2031)

10.2 Middle East & Africa Lung Cancer Genomic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lung Cancer Genomic Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Lung Cancer Genomic Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 CD Genomics

11.1.1 CD Genomics Company Details

11.1.2 CD Genomics Business Overview

11.1.3 CD Genomics Lung Cancer Genomic Testing Introduction

11.1.4 CD Genomics Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.1.5 CD Genomics Recent Development

11.2 Qiagen NV

11.2.1 Qiagen NV Company Details

11.2.2 Qiagen NV Business Overview

11.2.3 Qiagen NV Lung Cancer Genomic Testing Introduction

11.2.4 Qiagen NV Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.2.5 Qiagen NV Recent Development

11.3 Laboratory Corporation of America Holdings

11.3.1 Laboratory Corporation of America Holdings Company Details

11.3.2 Laboratory Corporation of America Holdings Business Overview

11.3.3 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Introduction

11.3.4 Laboratory Corporation of America Holdings Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.3.5 Laboratory Corporation of America Holdings Recent Development

11.4 NeoGenomics Laboratories

11.4.1 NeoGenomics Laboratories Company Details

11.4.2 NeoGenomics Laboratories Business Overview

11.4.3 NeoGenomics Laboratories Lung Cancer Genomic Testing Introduction

11.4.4 NeoGenomics Laboratories Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.4.5 NeoGenomics Laboratories Recent Development

11.5 Agilent Technologies Inc.

11.5.1 Agilent Technologies Inc. Company Details

11.5.2 Agilent Technologies Inc. Business Overview

11.5.3 Agilent Technologies Inc. Lung Cancer Genomic Testing Introduction

11.5.4 Agilent Technologies Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.5.5 Agilent Technologies Inc. Recent Development

11.6 Illumina Inc.

11.6.1 Illumina Inc. Company Details

11.6.2 Illumina Inc. Business Overview

11.6.3 Illumina Inc. Lung Cancer Genomic Testing Introduction

11.6.4 Illumina Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.6.5 Illumina Inc. Recent Development

11.7 Thermo Fischer Scientific Inc.

11.7.1 Thermo Fischer Scientific Inc. Company Details

11.7.2 Thermo Fischer Scientific Inc. Business Overview

11.7.3 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Introduction

11.7.4 Thermo Fischer Scientific Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.7.5 Thermo Fischer Scientific Inc. Recent Development

11.8 Abbott Laboratories Inc.

11.8.1 Abbott Laboratories Inc. Company Details

11.8.2 Abbott Laboratories Inc. Business Overview

11.8.3 Abbott Laboratories Inc. Lung Cancer Genomic Testing Introduction

11.8.4 Abbott Laboratories Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.8.5 Abbott Laboratories Inc. Recent Development

11.9 Quest Diagnostics Inc.

11.9.1 Quest Diagnostics Inc. Company Details

11.9.2 Quest Diagnostics Inc. Business Overview

11.9.3 Quest Diagnostics Inc. Lung Cancer Genomic Testing Introduction

11.9.4 Quest Diagnostics Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.9.5 Quest Diagnostics Inc. Recent Development

11.10 OncoDNA

11.10.1 OncoDNA Company Details

11.10.2 OncoDNA Business Overview

11.10.3 OncoDNA Lung Cancer Genomic Testing Introduction

11.10.4 OncoDNA Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.10.5 OncoDNA Recent Development

11.11 Centogene N.V.

11.11.1 Centogene N.V. Company Details

11.11.2 Centogene N.V. Business Overview

11.11.3 Centogene N.V. Lung Cancer Genomic Testing Introduction

11.11.4 Centogene N.V. Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.11.5 Centogene N.V. Recent Development

11.12 Admera Health

11.12.1 Admera Health Company Details

11.12.2 Admera Health Business Overview

11.12.3 Admera Health Lung Cancer Genomic Testing Introduction

11.12.4 Admera Health Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.12.5 Admera Health Recent Development

11.13 CeGaT GmbH

11.13.1 CeGaT GmbH Company Details

11.13.2 CeGaT GmbH Business Overview

11.13.3 CeGaT GmbH Lung Cancer Genomic Testing Introduction

11.13.4 CeGaT GmbH Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.13.5 CeGaT GmbH Recent Development

11.14 OPKO Health Inc.

11.14.1 OPKO Health Inc. Company Details

11.14.2 OPKO Health Inc. Business Overview

11.14.3 OPKO Health Inc. Lung Cancer Genomic Testing Introduction

11.14.4 OPKO Health Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.14.5 OPKO Health Inc. Recent Development

11.15 F. Hoffmann-La Roche AG.

11.15.1 F. Hoffmann-La Roche AG. Company Details

11.15.2 F. Hoffmann-La Roche AG. Business Overview

11.15.3 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Introduction

11.15.4 F. Hoffmann-La Roche AG. Revenue in Lung Cancer Genomic Testing Business (2020-2025)

11.15.5 F. Hoffmann-La Roche AG. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CD Genomics

Qiagen NV

Laboratory Corporation of America Holdings

Neogenomics Laboratories

Agilent Technologies Inc

Illumina Inc

Thermo-Fischer Scientific, Inc.

Abbott Laboratories Inc

Quest Diagnostics Inc.

OncoDNA

CENTOGENE N.V

Admera Health

CeGaT GmbH

OPKO Health Inc

F. Hoffmann-La Roche AG

List of Tables

Table 1. Global Lung Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Liquid Biopsy

Table 3. Key Players of Tissue Biopsy

Table 4. Global Lung Cancer Genomic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Lung Cancer Genomic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Lung Cancer Genomic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Lung Cancer Genomic Testing Market Share by Region (2020-2025)

Table 8. Global Lung Cancer Genomic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Lung Cancer Genomic Testing Market Share by Region (2026-2031)

Table 10. Lung Cancer Genomic Testing Market Trends

Table 11. Lung Cancer Genomic Testing Market Drivers

Table 12. Lung Cancer Genomic Testing Market Challenges

Table 13. Lung Cancer Genomic Testing Market Restraints

Table 14. Global Lung Cancer Genomic Testing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Lung Cancer Genomic Testing Market Share by Players (2020-2025)

Table 16. Global Top Lung Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Genomic Testing as of 2024)

Table 17. Ranking of Global Top Lung Cancer Genomic Testing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Lung Cancer Genomic Testing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Lung Cancer Genomic Testing, Headquarters and Area Served

Table 20. Global Key Players of Lung Cancer Genomic Testing, Product and Application

Table 21. Global Key Players of Lung Cancer Genomic Testing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Lung Cancer Genomic Testing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Lung Cancer Genomic Testing Revenue Market Share by Type (2020-2025)

Table 25. Global Lung Cancer Genomic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Lung Cancer Genomic Testing Revenue Market Share by Type (2026-2031)

Table 27. Global Lung Cancer Genomic Testing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Lung Cancer Genomic Testing Revenue Market Share by Application (2020-2025)

Table 29. Global Lung Cancer Genomic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Lung Cancer Genomic Testing Revenue Market Share by Application (2026-2031)

Table 31. North America Lung Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Lung Cancer Genomic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Lung Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Lung Cancer Genomic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Lung Cancer Genomic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Lung Cancer Genomic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Lung Cancer Genomic Testing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Lung Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Lung Cancer Genomic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Lung Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Lung Cancer Genomic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Lung Cancer Genomic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 46. CD Genomics Company Details

Table 47. CD Genomics Business Overview

Table 48. CD Genomics Lung Cancer Genomic Testing Product

Table 49. CD Genomics Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 50. CD Genomics Recent Development

Table 51. Qiagen NV Company Details

Table 52. Qiagen NV Business Overview

Table 53. Qiagen NV Lung Cancer Genomic Testing Product

Table 54. Qiagen NV Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 55. Qiagen NV Recent Development

Table 56. Laboratory Corporation of America Holdings Company Details

Table 57. Laboratory Corporation of America Holdings Business Overview

Table 58. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product

Table 59. Laboratory Corporation of America Holdings Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 60. Laboratory Corporation of America Holdings Recent Development

Table 61. NeoGenomics Laboratories Company Details

Table 62. NeoGenomics Laboratories Business Overview

Table 63. NeoGenomics Laboratories Lung Cancer Genomic Testing Product

Table 64. NeoGenomics Laboratories Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 65. NeoGenomics Laboratories Recent Development

Table 66. Agilent Technologies Inc. Company Details

Table 67. Agilent Technologies Inc. Business Overview

Table 68. Agilent Technologies Inc. Lung Cancer Genomic Testing Product

Table 69. Agilent Technologies Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 70. Agilent Technologies Inc. Recent Development

Table 71. Illumina Inc. Company Details

Table 72. Illumina Inc. Business Overview

Table 73. Illumina Inc. Lung Cancer Genomic Testing Product

Table 74. Illumina Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 75. Illumina Inc. Recent Development

Table 76. Thermo Fischer Scientific Inc. Company Details

Table 77. Thermo Fischer Scientific Inc. Business Overview

Table 78. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product

Table 79. Thermo Fischer Scientific Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 80. Thermo Fischer Scientific Inc. Recent Development

Table 81. Abbott Laboratories Inc. Company Details

Table 82. Abbott Laboratories Inc. Business Overview

Table 83. Abbott Laboratories Inc. Lung Cancer Genomic Testing Product

Table 84. Abbott Laboratories Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 85. Abbott Laboratories Inc. Recent Development

Table 86. Quest Diagnostics Inc. Company Details

Table 87. Quest Diagnostics Inc. Business Overview

Table 88. Quest Diagnostics Inc. Lung Cancer Genomic Testing Product

Table 89. Quest Diagnostics Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 90. Quest Diagnostics Inc. Recent Development

Table 91. OncoDNA Company Details

Table 92. OncoDNA Business Overview

Table 93. OncoDNA Lung Cancer Genomic Testing Product

Table 94. OncoDNA Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 95. OncoDNA Recent Development

Table 96. Centogene N.V. Company Details

Table 97. Centogene N.V. Business Overview

Table 98. Centogene N.V. Lung Cancer Genomic Testing Product

Table 99. Centogene N.V. Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 100. Centogene N.V. Recent Development

Table 101. Admera Health Company Details

Table 102. Admera Health Business Overview

Table 103. Admera Health Lung Cancer Genomic Testing Product

Table 104. Admera Health Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 105. Admera Health Recent Development

Table 106. CeGaT GmbH Company Details

Table 107. CeGaT GmbH Business Overview

Table 108. CeGaT GmbH Lung Cancer Genomic Testing Product

Table 109. CeGaT GmbH Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 110. CeGaT GmbH Recent Development

Table 111. OPKO Health Inc. Company Details

Table 112. OPKO Health Inc. Business Overview

Table 113. OPKO Health Inc. Lung Cancer Genomic Testing Product

Table 114. OPKO Health Inc. Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 115. OPKO Health Inc. Recent Development

Table 116. F. Hoffmann-La Roche AG. Company Details

Table 117. F. Hoffmann-La Roche AG. Business Overview

Table 118. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product

Table 119. F. Hoffmann-La Roche AG. Revenue in Lung Cancer Genomic Testing Business (2020-2025) & (US$ Million)

Table 120. F. Hoffmann-La Roche AG. Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Lung Cancer Genomic Testing Picture

Figure 2. Global Lung Cancer Genomic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lung Cancer Genomic Testing Market Share by Type: 2024 VS 2031

Figure 4. Liquid Biopsy Features

Figure 5. Tissue Biopsy Features

Figure 6. Global Lung Cancer Genomic Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Lung Cancer Genomic Testing Market Share by Application: 2024 VS 2031

Figure 8. Hospitals/Clinics Case Studies

Figure 9. Research Organization Case Studies

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Lung Cancer Genomic Testing Report Years Considered

Figure 12. Global Lung Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Lung Cancer Genomic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Lung Cancer Genomic Testing Market Share by Region: 2024 VS 2031

Figure 15. Global Lung Cancer Genomic Testing Market Share by Players in 2024

Figure 16. Global Top Lung Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Genomic Testing as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Genomic Testing Revenue in 2024

Figure 18. North America Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Lung Cancer Genomic Testing Market Share by Country (2020-2031)

Figure 20. United States Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Lung Cancer Genomic Testing Market Share by Country (2020-2031)

Figure 24. Germany Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Lung Cancer Genomic Testing Market Share by Region (2020-2031)

Figure 32. China Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Lung Cancer Genomic Testing Market Share by Country (2020-2031)

Figure 40. Mexico Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Lung Cancer Genomic Testing Market Share by Country (2020-2031)

Figure 44. Turkey Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Lung Cancer Genomic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. CD Genomics Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 48. Qiagen NV Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 49. Laboratory Corporation of America Holdings Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 50. NeoGenomics Laboratories Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 51. Agilent Technologies Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 52. Illumina Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 53. Thermo Fischer Scientific Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 54. Abbott Laboratories Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 55. Quest Diagnostics Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 56. OncoDNA Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 57. Centogene N.V. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 58. Admera Health Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 59. CeGaT GmbH Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 60. OPKO Health Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 61. F. Hoffmann-La Roche AG. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Genomic Testing in Cancer Market Research Report 2024

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Global Inherited Cancer Genome Testing Market Research Report 2024

Global Next Generation Tumor Genetic Testing Market Research Report 2024

Global Genomic Biomarkers Market Research Report 2024

Global Cancer Oncology Testing Market Research Report 2024

Global Breast Cancer Predictive Genetic Testing Market Research Report 2024

Cancer Gene Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Test Kit Market Research Report 2024

Global Genotyping Test Market Research Report 2025

Global Lung Cancer Screening Software Market Research Report 2024

Global Predictive Genetic Testing And Consumer Genomics Market Research Report 2024

Global Lung Cancer Diagnostics Kit Market Research Report 2024

Global Tumor Biomarker Test Market Research Report 2024

Global DNA Genetic Testing Market Research Report 2024

Global Tumor Gene Test Service Market Research Report 2025

Global Chest Cancer Molecular Diagnostics Market Research Report 2024

Global Lung Cancer Diagnostic Tests Market Research Report 2024

Lung Cancer Liquid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions